Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019214 (
hepatosplenomegaly
)
4,408
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Adult hematopoiesis requires tightly regulated cell-cell interactions between hematopoietic cells and the bone marrow stromal microenvironment. We addressed the question if the ectodomain sheddase
ADAM10
is essential to regulate adult hematopoiesis. Induced
ADAM10
deletion in hematopoietic cells resulted in morphological and histological abnormalities that resemble an unclassified myeloproliferative disorder (MPD). The MPD was characterized by an expansion of granulocytic subpopulations and their infiltration of peripheral hematopoietic tissues, the development of
hepatosplenomegaly
with extramedullary erythropoiesis, lymphnodepathy and death of the mice around 20weeks after induction.
ADAM10
expression analysis during the different stages of the MPD revealed that non-targeted hematopoietic cells repopulated the immune system of the
ADAM10
-deficient mice. Examination of mice with a myeloid- or epidermis-specific deletion of
ADAM10
and bone marrow transplantation (BMT) experiments indicated that the development of the MPD can be triggered by non-cell autonomous effects. We found that plasma levels of clinical markers for MPD such as G-CSF, TIMP-1 and IL-16 were significantly elevated in
ADAM10
-deficient mice. Our findings indicate that a tightly controlled
ADAM10
expression is needed to balance hematopoietic cell-fate decisions in adult mice.
...
PMID:Regulation of adult hematopoiesis by the a disintegrin and metalloproteinase 10 (ADAM10). 2423 82